Literature DB >> 23312429

Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.

Katherine Schaumberg1, Alexis Kuerbis, Jon Morgenstern, Frederick Muench.   

Abstract

The current study examines participants' attributions of change in a double-blind, randomized controlled trial of problem drinkers wanting to moderate their alcohol consumption. Participants were assigned to 12 weeks of naltrexone or placebo, which was paired with either combined motivational interviewing and cognitive behavioral therapy (MBSCT) along with an enhanced medication management intervention or enhanced medication management only. Upon treatment completion, a questionnaire assessed participants' attributions of change along with their self-efficacy in their ability to maintain treatment gains. Participants differed in strength of attributions of change and self-efficacy according to both their therapy condition and their hypothesized medication condition. Specifically, those in the MBSCT condition who hypothesized that they received placebo displayed greater confidence in continuing changes without medication compared with the other groups. How treatment condition and attributions of change relate to self-efficacy for long-term maintenance of treatment gains are discussed.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23312429      PMCID: PMC3556396          DOI: 10.1016/j.beth.2012.07.001

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  29 in total

1.  A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions.

Authors:  K M Carroll; C Nich; R L Sifry; K F Nuro; T L Frankforter; S A Ball; L Fenton; B J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2000-01-01       Impact factor: 4.492

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia.

Authors:  Massimo Biondi; Angelo Picardi
Journal:  Psychother Psychosom       Date:  2003 Mar-Apr       Impact factor: 17.659

4.  A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men.

Authors:  Jon Morgenstern; Alexis N Kuerbis; Andrew C Chen; Christopher W Kahler; Donald A Bux; Henry R Kranzler
Journal:  J Consult Clin Psychol       Date:  2012-05-21

5.  The reliability of the CIDI-SAM: a comprehensive substance abuse interview.

Authors:  L B Cottler; L N Robins; J E Helzer
Journal:  Br J Addict       Date:  1989-07

6.  Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation.

Authors:  M E McCaul; G S Wand; R Stauffer; S M Lee; C A Rohde
Journal:  Neuropsychopharmacology       Date:  2001-10       Impact factor: 7.853

7.  Random assignment to abstinence and controlled drinking: evaluation of a cognitive-behavioral program for problem drinkers.

Authors:  M Sanchez-Craig; H M Annis; A R Bornet; K R MacDonald
Journal:  J Consult Clin Psychol       Date:  1984-06

8.  Cognitive and behavioural factors as predictors of abstinence following treatment for alcohol dependence.

Authors:  I Vielva; I Iraurgi
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

9.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

10.  Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.

Authors:  Henry R Kranzler; Stephen Armeli; Richard Feinn; Howard Tennen
Journal:  J Consult Clin Psychol       Date:  2004-04
View more
  4 in total

1.  Prosocial Peers as Risk, Protective, and Promotive Factors for the Prevention of Delinquency and Drug Use.

Authors:  Glenn D Walters
Journal:  J Youth Adolesc       Date:  2019-06-18

2.  Change in posttraumatic stress disorder-related thoughts during treatment: Do thoughts drive change when pills are involved?

Authors:  Sheila A M Rauch; H Myra Kim; Margaret R Venners; Katherine E Porter; Sonya B Norman; Naomi M Simon; Barbara O Rothbaum; Peter W Tuerk; Ronald E Acierno; Eric Bui; Corey Powell; Erin R Smith; Elizabeth Goetter; Lauren B McSweeney
Journal:  J Trauma Stress       Date:  2021-12-31

3.  Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking.

Authors:  Henry R Kranzler; Stephen Armeli; Reagan Wetherill; Richard Feinn; Howard Tennen; Joel Gelernter; Jonathan Covault; Timothy Pond
Journal:  Addict Biol       Date:  2014-12-15       Impact factor: 4.280

4.  A review of existing treatments for substance abuse among the elderly and recommendations for future directions.

Authors:  Alexis Kuerbis; Paul Sacco
Journal:  Subst Abuse       Date:  2013-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.